Therapeutic drug monitoring of eculizumab: Rationale for an individualized dosing schedule

MAbs
Philippe GataultHervé Watier

Abstract

The annual cost of eculizumab maintenance therapy in paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic-uremic syndrome (aHUS) exceeds $300,000 per patient. A better understanding of eculizumab pharmacokinetics and subsequent individual dose adjustment could reduce this cost. We measured the trough eculizumab concentration in 9 patients with maintenance therapy (aHUS, n = 7; PNH, n = 2) and determined: 1) the intra- and inter-individual variability; 2) the influence of weight on eculizumab pharmacokinetics; and 3) the rate of elimination of eculizumab following discontinuation. A one-compartment model was developed to describe the pharmacokinetics of eculizumab and predicted complement activity by body weight. Trough eculizumab concentrations were >50 µg/mL in 9/9, >100 µg/mL in 8/9, and >300 µg/mL in 5/9 of patients. Intra-individual variability was low but eculizumab concentrations, closely correlated with patient weight (R(2) = 0.66, p = 0.034), varied broadly (55 ± 12 to 733 ± 164 µg/mL). Pharmacokinetic modeling showed that the elimination half-life varied greatly, with an increase from 7.8 d in a patient weighing 100 kg to 19.5 d in a 40 kg patient. We predicted that infusions of 1200 mg could be spaced ever...Continue Reading

References

Jan 5, 1999·Clinical and Diagnostic Laboratory Immunology·T D JaskowskiH R Hill
Sep 23, 2006·The New England Journal of Medicine·Peter HillmenLucio Luzzatto
Jul 7, 2009·Journal of Pharmacokinetics and Pharmacodynamics·Leonid Gibiansky, Ekaterina Gibiansky
Sep 8, 2010·Clinical Pharmacokinetics·Nathanael L Dirks, Bernd Meibohm
Jun 7, 2013·The New England Journal of Medicine·C M LegendreC Loirat
Sep 12, 2013·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Fadi FakhouriVéronique Frémeaux-Bacchi
Oct 4, 2013·The New England Journal of Medicine·Christophe M LegendreChantal Loirat
Oct 4, 2013·The New England Journal of Medicine·Tetsuya TanimotoMasahiro Kami
Feb 14, 2014·The New England Journal of Medicine·Jun-ichi NishimuraYuzuru Kanakura
Apr 30, 2014·Pediatric Blood & Cancer·Ulrike M ReissRussell E Ware
May 24, 2014·Journal of Thrombosis and Haemostasis : JTH·M CugnoG Ardissino
Nov 29, 2014·Blood·Richard M BurwickBruce B Feinberg

❮ Previous
Next ❯

Citations

Sep 3, 2016·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Aude ServaisYahsou Delmas
Sep 13, 2016·Journal of Immunoassay & Immunochemistry·Kheir Eddine KerbouaDjamila Batouche
Oct 27, 2016·Clinical and Experimental Immunology·C WehlingM Kirschfink
Mar 16, 2017·Clinical Pharmacology and Therapeutics·E VolokhinaL van den Heuvel
Jun 26, 2017·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Bénédicte Puissant-LubranoAntoine Blancher
Dec 19, 2017·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Vinod KrishnappaRupesh Raina
Oct 9, 2018·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Rupesh RainaArvind Bagga
Aug 15, 2019·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Catherine Monet-DidaillerJérôme Harambat
Jun 4, 2016·Current Opinion in Infectious Diseases·Esther Benamu, José G Montoya
Jan 7, 2020·Médecine sciences : M/S·Adeline BauvoisFrançois Maillot
Mar 24, 2020·International Journal of Laboratory Hematology·Miriam ArcaviAlberto Lazarowski
Nov 8, 2018·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Kioa L WijnsmaNicole C A J van de Kar
May 29, 2018·Clinical Pharmacokinetics·David TernantGilles Paintaud
Feb 23, 2020·Nature Reviews. Neurology·Yang Mao-DraayerKerstin Hellwig
Jan 30, 2019·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Gema Ariceta
Oct 18, 2019·Current Medicinal Chemistry·Taku Fukuzawa, Junichi Nezu
Dec 29, 2020·Frontiers in Immunology·Marion OrtPriska Kaufmann

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
enzyme-linked immunosorbent assay

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Yuri B Pride
The New England Journal of Medicine
Jaswinder SinghManinder Pabla
The New England Journal of Medicine
Morihito TakitaMasahiro Kami
© 2021 Meta ULC. All rights reserved